Xiansheng Pharmaceutical (02096) announced that on April 10, 2024, it cost approximately HK$7.881 million to repurchase 147...
According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on April 10, 2024, it spent approximately HK$7.881 million to repurchase 1.47 million shares.